Stay updated on Nivolumab After SIRT for HCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.

Latest updates to the Nivolumab After SIRT for HCC Clinical Trial page
- Check6 days agoChange DetectedSubstantive content on the study page is replaced by a 403 Forbidden error. This blocks access to the study's details and related information.SummaryDifference18%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, reflecting a new page version in the footer.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor platform update and does not alter the study details or user interactions on the page.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a software update to the page's release version.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, reflecting a backend/template update. It represents a maintenance release rather than a change to the study details or public content.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2. This indicates a minor update or refresh to the ClinicalTrials.gov study record.SummaryDifference0.1%

Stay in the know with updates to Nivolumab After SIRT for HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.